市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Pluri Inc. | 混合的 | 混合的 |
AIStockmoo 评分
-0.8
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.83 |
|
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company’s technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 43.87% |
| 机构持股比例 | 19.40% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Sima Wealth Partners, Llc | 30 Jun 2026 | 350 |
| Activest Wealth Management | 30 Jun 2026 | 86 |
| Winch Advisory Services, Llc | 30 Jun 2026 | 26 |
| Tfc Financial Management, Inc. | 30 Jun 2026 | 19 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合